Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration.
Platelet-derived growth factor receptor alpha (PDGFRα) serves as an entry receptor for the human cytomegalovirus (HCMV), and soluble PDGFRα-Fc can neutralize HCMV at a half-maximal effective concentration (EC50) of about 10 ng/ml. While this indicates a potential for usage as an HCMV entry inhibitor...
Saved in:
| Main Authors: | Svenja Feldmann, Immanuel Grimm, Dagmar Stöhr, Chiara Antonini, Peter Lischka, Christian Sinzger, Cora Stegmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-03-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009471&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Characterization of PDGFR-α/PDGF-A and c-KIT/SCF in Gliosarcomas
by: Rui M. Reis, et al.
Published: (2005-01-01) -
Fc-engineered antibodies with immune effector functions completely abolished.
by: Ian Wilkinson, et al.
Published: (2021-01-01) -
Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review
by: Chao-Nan Ma, et al.
Published: (2024-11-01) -
Endothelial Cells Promote Migration of Mesenchymal Stem Cells via PDGF-BB/PDGFRβ-Src-Akt in the Context of Inflammatory Microenvironment upon Bone Defect
by: Sihao He, et al.
Published: (2022-01-01) -
PDGFR‐β and kidney fibrosis
by: Alberto Ortiz
Published: (2020-02-01)